# University Medical Center Groningen

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/university-medical-center-groningen/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 70.9 |
| Citations | 10,639,698 |
| City | Groningen |
| Country | NL |
| Description | University Medical Center Groningen is a research organisation in Groningen, NL. OpenAlex records 82,147 works and 10,639,698 citations for it. 16,590 researchers list it as their most recent affiliation. |
| Homepage | https://www.umcg.nl |
| OpenAlex ID | https://openalex.org/I1334415907 |
| Region | Groningen |
| Researchers | 16,590 |
| ROR ID | https://ror.org/03cv38k47 |
| Type | healthcare |
| Works | 82,147 |

## University papers

Showing 12 of 774.

- [2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure](https://scholariq.org/papers/2021-esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart/)
- [K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification](https://scholariq.org/papers/k-doqi-clinical-practice-guidelines-for-chronic-kidney-disease-evaluation/)
- [2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)](https://scholariq.org/papers/2020-esc-guidelines-for-the-diagnosis-and-management-of-atrial-fibrillation/)
- [Biological insights from 108 schizophrenia-associated genetic loci](https://scholariq.org/papers/biological-insights-from-108-schizophrenia-associated-genetic-loci/)
- [Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes](https://scholariq.org/papers/canagliflozin-and-cardiovascular-and-renal-events-in-type-2-diabetes/)
- [Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy](https://scholariq.org/papers/effects-of-losartan-on-renal-and-cardiovascular-outcomes-in-patients-with-type-2/)
- [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC](https://scholariq.org/papers/esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-2/)
- [2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS](https://scholariq.org/papers/2016-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in/)
- [2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS](https://scholariq.org/papers/2016-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in-5/)
- [2021 ESC Guidelines on cardiovascular disease prevention in clinical practice](https://scholariq.org/papers/2021-esc-guidelines-on-cardiovascular-disease-prevention-in-clinical-practice/)
- [Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy](https://scholariq.org/papers/canagliflozin-and-renal-outcomes-in-type-2-diabetes-and-nephropathy/)
- [2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure](https://scholariq.org/papers/2016-esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-2/)

## University researchers

Showing 15 of 35.

- [Dirk J. van Veldhuisen](https://scholariq.org/researchers/dirk-j-van-veldhuisen/)
- [Adriaan A. Voors](https://scholariq.org/researchers/adriaan-a-voors/)
- [Dick de Zeeuw](https://scholariq.org/researchers/dick-de-zeeuw/)
- [Ron T. Gansevoort](https://scholariq.org/researchers/ron-t-gansevoort/)
- [Johan Ormel](https://scholariq.org/researchers/johan-ormel/)
- [Catharina A. Hartman](https://scholariq.org/researchers/catharina-a-hartman/)
- [Kevin Damman](https://scholariq.org/researchers/kevin-damman/)
- [Robbert Sanderman](https://scholariq.org/researchers/robbert-sanderman/)
- [Peter van der Meer](https://scholariq.org/researchers/peter-van-der-meer/)
- [Ingeborg M. Bajema](https://scholariq.org/researchers/ingeborg-m-bajema/)
- [Sijmen A. Reijneveld](https://scholariq.org/researchers/sijmen-a-reijneveld/)
- [Nomdo M. Jansonius](https://scholariq.org/researchers/nomdo-m-jansonius/)
- [Jozine M. ter Maaten](https://scholariq.org/researchers/jozine-m-ter-maaten/)
- [Erwin Birnie](https://scholariq.org/researchers/erwin-birnie/)
- [Marie L. A. Schuttelaar](https://scholariq.org/researchers/marie-l-a-schuttelaar/)

## University top topics

Showing 8 of 25.

- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Medical Imaging Techniques and Applications](https://scholariq.org/topics/medical-imaging-techniques-and-applications/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.